An immunohistochemical study examining membrane-bound Fas-L expression found that, contrary to expectation, Fas-L expression is not increased in MSS cancers and thus does not explain the less prominent lymphocyte infiltrates seen in these cancers [75]. The gene discussed is FASLG; the disease is Marinesco-Sjogren syndrome.